Download Files:
Erdosteine
$88 – $581
Products Details
Product Description
– Erdosteine inhibits lipopolysaccharide (LPS)-induced NF-κB activation[1][2]. Erdosteine has muco-modulatory, anti-bacterial, anti-inflammatory and anti-oxidant effects[3].
Web ID
– HY-B0289
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C8H11NO4S2
References
– [1]Oktar S, et al. Beneficial effect of erdosteine on methotrexate-induced testicular toxicity in mice. Toxicol Ind Health. 2010 Aug;26(7):433-8.|[2]Park JS, et al. Anti-inflammatory Effect of Erdosteine in Lipopolysaccharide-Stimulated RAW 264.7 Cells. Inflammation. 2016 Aug;39(4):1573-81.|[3]Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
CAS Number
– 84611-23-4
Molecular Weight
– 249.31
Compound Purity
– 99.83
SMILES
– O=C(O)CSCC(NC(CCS1)C1=O)=O
Clinical Information
– Launched
Research Area
– Infection; Metabolic Disease; Inflammation/Immunology
Solubility
– DMSO : 50 mg/mL (ultrasonic)|H2O : 6.67 mg/mL (ultrasonic)
Target
– Bacterial;NF-κB
Isoform
– NF-κB
Pathway
– Anti-infection;NF-κB
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
